2024

Ionnis Oikonomakos, Dresden, Germany

 Advancing Adrenal Stem Cell Transplantation for Precision Therapies in Congenital Adrenal Hyperplasia, 130 000 €

Antonin Lamazière, Paris, France

 Advancements in Congenital Adrenal Hyperplasia (CAH) screening: The Potential of 11-ketotestosterone and 21-Deoxycortisone as second tier confirmation Diagnostic Marker, 55 000 €

Antonius E.van Herwaarden- Rabdoud UMC -Netherlands

Clinical implications of 11-oxygenated androgens in patients with congenital adrenal hvperplasia due to 21-hydroxylase deficiency-CLINOXY study “ , 150 000 €